Business · 13/03/2024
FDA Announces Draft Guidance on Annual Labeling Changes for Nonprescription Drug Products
The FDA has released a draft guidance for industry on documenting minor labeling changes for nonprescription drug products, aiming to streamline the process and reduce burden on industry and FDA.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →